Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

This is a one-time financial adjustment related to accounting that has no bearing on ... often prescribed off-label for any type of weight loss. During the quarter, Zepbound became the market ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

The reality, though, is that both drugs are often prescribed off-label for any type of weight loss. During the quarter, Zepbound became ... said it had no interest in negotiating an exclusive ...

(AP) — A Michigan school did not violate the free-speech rights of a third-grade student who was told to remove a hat that had an image of an ... included a record label, a fashion brand ...

In a statement, Ro said it will make Zepbound available as a treatment option with an on-label prescription from ... manager CVS Health said it would no longer cover its weight-loss therapy ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

Lilly now plans to file for approval to add the heart failure indication to the label for tirzepatide, which is already sold as Mounjaro for type 2 diabetes and Zepbound for obesity, later this year.

Sophia Umansky faced hair loss after using Mounjaro for rapid weight loss. Is this diabetes drug really safe? Here's what you ...

Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...

Image courtesy of Clean Composting ... chance of someone tossing something in because a label said it was compostable, when it really is not for their specific program. #2: Focus on What is Inside ...